E3XBio Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Investors
  • 1

E3XBio General Information


Developers of inhibitors and activators of E3 Ubiquitin ligases intended to be used for drug discovery and development. The company's platform offers streamlined screening paradigm and direct cellular and animal model assays, enabling healthcare institutions to avail a simplified, pragmatic drug discovery approach to identify first-in-class small molecules specifically directed towards Ub E3 HECT ligases.

Contact Information

Ownership Status
Privately Held (no backing)
Financing Status
Primary Industry
Drug Discovery
Corporate Office
  • San Francisco, CA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

E3XBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Grant 01-Sep-2014 Completed Generating Revenue
To view E3XBio’s complete valuation and funding history, request access »

E3XBio Patents

E3XBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140327158-A1 Method for identifying modulators of ubiquitin ligases Active 02-May-2013 00000000 0
US-9464311-B2 Method for identifying modulators of ubiquitin ligases Inactive 02-May-2013 00000000 0
AU-2014259671-A1 Method for identifying modulators of ubiquitin ligases Inactive 02-May-2013 00000000
CA-2909964-A1 Method for identifying modulators of ubiquitin ligases Inactive 02-May-2013 00000000
EP-2992109-A2 Method for identifying modulators of ubiquitin ligases Inactive 02-May-2013 C12Q1/25
To view E3XBio’s complete patent history, request access »

E3XBio Executive Team (3)

Name Title Board Seat
Lori Rafield Ph.D Co-Founder & Chief Executive Officer
Paul Godowski Ph.D Co-Founder & Chief Scientific Officer
William Harte Ph.D Co-Founder & Vice President, Technology Platforms
To view E3XBio’s complete executive team members history, request access »

E3XBio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Breakout Labs Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view E3XBio’s complete investors history, request access »


  • When was E3XBio founded?

    E3XBio was founded in 2013.

  • Who is the founder of E3XBio?

    Lori Rafield Ph.D, Paul Godowski Ph.D, and William Harte Ph.D are the founders of E3XBio.

  • Who is the CEO of E3XBio?

    Lori Rafield Ph.D is the CEO of E3XBio.

  • Where is E3XBio headquartered?

    E3XBio is headquartered in San Francisco, CA.

  • What industry is E3XBio in?

    E3XBio’s primary industry is Drug Discovery.

  • Is E3XBio a private or public company?

    E3XBio is a Private company.

  • What is E3XBio’s current revenue?

    The current revenue for E3XBio is 00000.

  • Who are E3XBio’s investors?

    Breakout Labs has invested in E3XBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »